Electromedical Products International, Inc.
- Country
- đşđ¸United States
- Ownership
- Holding
- Established
- 1981-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.alpha-stim.com
Clinical Trials
6
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)⢠Click on a phase to view related trials
CES for the Treatment of GAD in Young Adults
- Conditions
- Generalized Anxiety Disorder
- First Posted Date
- 2023-11-09
- Last Posted Date
- 2025-10-28
- Lead Sponsor
- Electromedical Products International, Inc.
- Target Recruit Count
- 130
- Registration Number
- NCT06124014
- Locations
- đşđ¸
Carolina Center for Neurostimulation, Chapel Hill, North Carolina, United States
Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Depression
- Conditions
- DepressionMajor Depressive DisordertACS
- First Posted Date
- 2023-03-16
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Electromedical Products International, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT05772702
- Locations
- đşđ¸
Carolina Center for Neurostimulation, Chapel Hill, North Carolina, United States
Alpha-Stim AID and Major Depressive Disorder
- Conditions
- Depressive Disorder, Major
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Electromedical Products International, Inc.
- Target Recruit Count
- 230
- Registration Number
- NCT04963907
- Locations
- đŹđ§
University of Nottingham, Nottingham, United Kingdom
Neural Mechanisms With CES in Depression
- Conditions
- Depression
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2023-11-24
- Lead Sponsor
- Electromedical Products International, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT04587531
- Locations
- đŹđ§
Oxford Brooke University, Oxford, United Kingdom
Efficacy of Cranial Electrotherapy Stimulation (CES) for the Treatment of Major Depressive Disorder
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2017-07-19
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Electromedical Products International, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT03222752
- Locations
- đşđ¸
Advanced Psychotherapeutics, Forest, Virginia, United States
- Prev
- 1
- 2
- Next
News
FDA Grants Breakthrough Device Designations for Novel Neuromodulation Therapies Targeting PTSD and MDD
⢠Wave Neuroscience's MeRT system received FDA Breakthrough Device Designation for adjunctive treatment of PTSD, addressing the critical need for effective, non-pharmacologic options. ⢠Pulvinar Neuro, a subsidiary of EPI, obtained FDA Breakthrough Device Designation for its Closed-Loop tACS device, aiming to provide rapid relief from Major Depressive Disorder (MDD) symptoms. ⢠Both devices leverage personalized neuromodulation techniques, tailoring treatment to individual brain activity patterns, potentially transforming mental health care. ⢠The FDA's designation is expected to accelerate the development and review processes for these innovative therapies, offering hope for improved outcomes in underserved patient populations.